An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma
- PMID: 32985354
- PMCID: PMC7534087
- DOI: 10.1177/1533033820956998
An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma
Abstract
Objective: We aim to identify several microRNAs (miRNAs/miRs)-messenger RNAs (mRNAs) biomarkers correlated to nasopharyngeal carcinoma (NPC) based on an integrated analysis of miRNA and mRNAs microarray expression profiles.
Methods: The available mRNA and miRNA microarray datasets were retrieved from Gene Expression Omnibus (GEO) database according to pre-determined screening criteria. Differentially expressed miRNA and mRNAs (DEmiRNAs and DEmRNAs) were extracted between NPC and noncancerous nasopharyngeal tissues. The target genes of DEmiRNAs were predicted with miRTarBase followed by the construction of DEmiRNAs-target DEmRNAs network, and functional analyses were performed. The DEmiRNAs expressions were validated and the performance of these DEmiRNAs was assessed by the area under the curve (AUC) values. Finally, the correlations between DEmiRNAs and specific clinical factors were analyzed.
Results: There were 1140 interaction pairs (including let-7d/f-MYC/HMGA2 and miR-452-ITGA9) in DEmiRNAs-target DEmRNAs network. The GO annotation analysis showed that several genes such as MYC, HMGA2 and ITGA9 primarily participated in cellular process. KEGG analysis showed that these targets were associated with cell cycle and cancer-related pathways. Down-regulated let-7(-d and -f) and up-regulated miR-452 were verified in datasets. The AUC values of these 3 DEmiRNAs (let-7d, let-7-f and miR-452) was 0.803, 0.835 and 0.735, respectively. Besides, miR-452 was significantly related to survival rate of NPC patients.
Conclusion: The findings implied let-7d/f-MYC/HMGA2 and miR-452-ITGA9 might be promising targets for the detection and treatment of NPC.
Keywords: biomarker; mRNA; microRNA; nasopharyngeal carcinoma.
Conflict of interest statement
Figures




Similar articles
-
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820985787. doi: 10.1177/1533033820985787. Technol Cancer Res Treat. 2020. PMID: 33371795 Free PMC article.
-
Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.Med Sci Monit. 2016 Jun 28;22:2215-34. doi: 10.12659/msm.896047. Med Sci Monit. 2016. PMID: 27350400 Free PMC article.
-
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.BMC Cancer. 2019 Aug 7;19(1):779. doi: 10.1186/s12885-019-5983-8. BMC Cancer. 2019. PMID: 31391008 Free PMC article.
-
Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.Crit Rev Eukaryot Gene Expr. 2019;29(6):539-549. doi: 10.1615/CritRevEukaryotGeneExpr.2019028740. Crit Rev Eukaryot Gene Expr. 2019. PMID: 32422009 Review.
-
Meta-analysis of transcriptomics data identifies potential biomarkers and their associated regulatory networks in gallbladder cancer.Gastroenterol Hepatol Bed Bench. 2022;15(4):311-325. doi: 10.22037/ghfbb.v15i4.2292. Gastroenterol Hepatol Bed Bench. 2022. PMID: 36762219 Free PMC article. Review.
Cited by
-
miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.Cancer Sci. 2021 Jun;112(6):2393-2404. doi: 10.1111/cas.14883. Epub 2021 Apr 5. Cancer Sci. 2021. PMID: 33728743 Free PMC article.
-
Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.Comput Intell Neurosci. 2022 Jun 7;2022:9022700. doi: 10.1155/2022/9022700. eCollection 2022. Comput Intell Neurosci. 2022. Retraction in: Comput Intell Neurosci. 2023 Nov 29;2023:9836790. doi: 10.1155/2023/9836790. PMID: 35712071 Free PMC article. Retracted.
-
Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma.Front Oncol. 2022 Mar 11;12:772816. doi: 10.3389/fonc.2022.772816. eCollection 2022. Front Oncol. 2022. PMID: 35359374 Free PMC article.
-
Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.Front Genet. 2021 Mar 24;12:656526. doi: 10.3389/fgene.2021.656526. eCollection 2021. Front Genet. 2021. PMID: 33841512 Free PMC article.
-
Identification of key biomarkers and potential therapeutic drugs in nasopharyngeal carcinoma based on comprehensive bioinformatics analysis.Discov Oncol. 2025 Jul 1;16(1):1189. doi: 10.1007/s12672-025-03047-4. Discov Oncol. 2025. PMID: 40591047 Free PMC article.
References
-
- Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–1024. - PubMed
-
- Razak AR, Siu LL, Liu FF, Ito E, O’Sullivan B, Chan K. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer. 2010;46(11):1967–1978. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. - PubMed
-
- Gao Y, Zhu SY, Dai Y, Lu BF, Lu L. Diagnostic accuracy of sonography versus magnetic resonance imaging for primary nasopharyngeal carcinoma. J Ultrasound Med. 2014;33(5):827–834. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous